Jump to content

Talk:Remdesivir

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
(Redirected from Talk:GS-5734)

A little late here but,

[edit]

I was surprised reading this article that there was very little mention of any of the past criticism of this drug. It sounds like it has had a lot of supporters and detractors since 2020, yet there is very little mention of any of the previous criticism (a couple sentences from what I read). The WHO recently walked back their criticism of the drug WHO recommends against the use of remdesivir in COVID-19 patients

And another recent article supports its use, along with the trials that WHO cites "Study Supports Use of Remdesivir for COVID-19 Patients on Low-Flow Oxygen or No Oxygen (hopkinsmedicine.org)"

So my question is: if the general scientific consensus has agreed that Remdesivir does work, does that mean there is little need of much discussion on any previous detractions or concerns about its quick approval? I would be of the opinion that the FDA not convening outside panels for this drug is notable, but I would like to know what this articles frequent editors think. (more sources: forbes and science.org) 134.134.139.84 (talk) 18:57, 11 October 2023 (UTC)[reply]

Any good sources giving an overview? So far as I can see the modern view is that remdesevir is a bit rubbish for COVID.[1] Bon courage (talk) 19:14, 11 October 2023 (UTC)[reply]

Semi-protected edit request on 28 January 2024

[edit]

Possible side effects include death. 73.121.109.117 (talk) 11:52, 28 January 2024 (UTC)[reply]

 Not done No source. Bon courage (talk) 12:06, 28 January 2024 (UTC)[reply]

Deletion of sourced material

[edit]

Hi @Smokefoot: I would appreciate it if you could please double-check your edit, as it removed a significant amount of sourced material, most of which was unrelated to patents. Thanks, Boghog (talk) 12:11, 6 October 2024 (UTC)[reply]